Image: NBC NewsU.S. provides experimental Ebola treatment for outbreak in Congo, bringing trials closer
β’ The U.S. government has provided doses of an experimental antibody drug developed by Mapp Biopharmaceutical to combat the Ebola outbreak in the Congo. β’ This decision marks a shift in policy, as the U.S. previously stated the treatment would only be available to high-risk American citizens. β’ The provision of these doses allows for the drug to be used in clinical trials, accelerating the process of determining its efficacy against the virus.
nbcnews.com